StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
500
This month
7
This week
1
This year
35
Today
1
Yesterday
1
Publishing Date
2024 - 03 - 28
3
2023 - 07 - 24
4
2023 - 05 - 15
3
2022 - 12 - 09
4
2022 - 09 - 13
3
2022 - 08 - 15
3
2022 - 07 - 04
2
2022 - 06 - 03
3
2022 - 05 - 24
2
2022 - 04 - 20
2
2022 - 04 - 19
2
2022 - 04 - 13
2
2022 - 03 - 28
2
2022 - 02 - 28
2
2022 - 02 - 24
2
2022 - 02 - 10
2
2022 - 02 - 01
2
2022 - 01 - 18
2
2022 - 01 - 14
2
2022 - 01 - 10
3
2021 - 12 - 21
2
2021 - 11 - 29
4
2021 - 11 - 19
2
2021 - 11 - 15
2
2021 - 11 - 11
2
2021 - 10 - 28
2
2021 - 10 - 21
2
2021 - 10 - 14
2
2021 - 10 - 07
2
2021 - 09 - 20
3
2021 - 09 - 16
3
2021 - 08 - 19
2
2021 - 08 - 12
3
2021 - 08 - 10
2
2021 - 08 - 05
3
2021 - 08 - 04
2
2021 - 07 - 29
2
2021 - 07 - 12
2
2021 - 06 - 25
2
2021 - 06 - 24
4
2021 - 06 - 23
2
2021 - 06 - 22
2
2021 - 06 - 21
3
2021 - 06 - 17
2
2021 - 06 - 10
2
2021 - 06 - 09
2
2021 - 06 - 04
5
2021 - 05 - 20
3
2021 - 05 - 06
2
2021 - 04 - 15
2
2021 - 04 - 14
2
2021 - 04 - 13
2
2021 - 03 - 22
2
2021 - 03 - 19
2
2021 - 03 - 18
2
2021 - 03 - 15
2
2021 - 03 - 11
3
2021 - 03 - 09
2
2021 - 03 - 04
2
2021 - 01 - 11
2
Sector
Communications
8
Distribution services
1
Electronic technology
3
Finance
7
Health services
3
Health technology
500
Manufacturing
15
N/a
4
Process industries
5
Professional, scientific, and technical services
8
Retail trade
1
Technology services
4
Tags
Agreement
12
Alliances
22
Antiviral
12
Application
9
Approval
16
Bioscience
10
Biotech
9
Biotech-bay
48
Biotech-beach
11
Breast cancer
22
Cancer
59
Chmp
11
Clinical-trials-phase-iii
14
Collaboration
23
Conference
14
Covid
14
Covid-19
16
Disease
20
Drug
25
Earnings
17
Events
20
Fda
21
Fda-approvals
10
Financial
23
Financial results
20
Genetown
12
Global
35
Growth
10
Health
13
Hepatitis
19
Hiv
41
Impact
9
Leukemia
10
License
13
Liver
11
Market
48
Money
9
N/a
225
People
19
Pharma
12
Pharmaceutical
10
Phase 2
9
Phase 3
9
Positive
13
Potential
10
Pre-clinical
9
Preclinical
10
Report
20
Research
54
Results
51
Sciences
30
Study
11
T-cell
32
Technology
9
Therapeutics
42
Therapy
52
Treatment
50
Trial
23
Trodelvy
15
Yescarta
14
Entities
Aadi biosciences inc
3
Abbott laboratories
12
Abbvie inc.
41
Adaptimmune therapeutics plc
3
Allovir, inc.
3
Alnylam pharmaceuticals, inc.
6
Amgen inc.
35
Arcellx, inc.
7
Arcus biosciences, inc.
3
Assembly biosciences, inc.
6
Astellas pharma inc
3
Astrazeneca plc
10
Baxter international inc.
3
Biocryst pharmaceuticals, inc.
13
Biogen inc.
6
Biomarin pharmaceutical inc.
4
Biontech se
3
Bluebird bio, inc.
4
Bristol-myers squibb company
45
Calliditas therapeutics ab
3
Crispr therapeutics ag
3
Cymabay therapeutics inc.
3
Editas medicine, inc.
3
Eli lilly and company
35
Exelixis, inc.
3
Galapagos nv
20
Genmab a/s
4
Gilead sciences, inc.
500
Glaxosmithkline plc
24
Hookipa pharma inc.
16
Humanigen, inc.
3
Immunogen, inc.
4
Intellia therapeutics, inc.
3
Johnson & johnson
43
Jounce therapeutics, inc.
25
Macrogenics, inc.
5
Merck & company, inc.
5
Morphosys ag
4
Novartis ag
28
Novo nordisk a/s
10
Nrx pharmaceuticals inc
3
Nurix therapeutics, inc.
4
Omeros corporation
14
Orange
8
Otonomy, inc.
13
Pfizer, inc.
27
Regeneron pharmaceuticals, inc.
11
Sangamo therapeutics, inc.
4
Sanofi
64
Sarepta therapeutics, inc.
4
Sorrento therapeutics, inc.
4
Takeda pharmaceutical company limited
15
Teva pharmaceutical industries ltd
10
Thermo fisher scientific inc
4
Vertex pharmaceuticals incorporated
6
Veru inc.
4
Viatris inc.
5
Vir biotechnology, inc.
6
Xeris pharmaceuticals, inc.
11
Xilio therapeutics inc
4
Symbols
AAPL
1197
ABB
1426
ABBV
1024
ABLZF
1165
ABT
1786
ACN
600
AMGN
742
ARVL
4293
AZN
664
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1611
F
641
FNCTF
7184
FRBA
598
GE
915
GLAXF
657
GOOG
1279
GOOGL
1278
GSK
883
HON
1783
HUBS
1400
IBM
654
INTC
955
IT
594
JNJ
4575
LLY
1708
LTUM
970
LYV
717
MDT
1285
MMM
938
MS
4283
MSFT
1200
MT
589
NOC
589
NOK
900
NOKBF
974
NVO
631
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1476
SAPGF
1230
SNOW
794
SNY
4534
SNYNF
3592
TEVJF
630
TMO
1622
VZ
1213
XYF
676
Exchanges
Amex
2
Nasdaq
500
Nyse
116
Crawled Date
2024 - 03 - 28
3
2023 - 12 - 12
3
2023 - 07 - 24
3
2023 - 06 - 01
3
2023 - 05 - 15
3
2022 - 12 - 09
4
2022 - 09 - 13
3
2022 - 06 - 03
3
2022 - 04 - 20
2
2022 - 04 - 19
2
2022 - 04 - 13
2
2022 - 03 - 31
2
2022 - 03 - 28
2
2022 - 02 - 28
2
2022 - 02 - 10
2
2022 - 02 - 01
2
2022 - 01 - 19
2
2022 - 01 - 14
2
2022 - 01 - 10
3
2021 - 12 - 21
2
2021 - 12 - 15
2
2021 - 11 - 29
4
2021 - 11 - 19
2
2021 - 11 - 15
2
2021 - 11 - 11
2
2021 - 10 - 28
2
2021 - 10 - 21
2
2021 - 10 - 14
2
2021 - 10 - 07
2
2021 - 09 - 20
3
2021 - 09 - 16
3
2021 - 08 - 19
2
2021 - 08 - 12
3
2021 - 08 - 10
2
2021 - 08 - 05
3
2021 - 08 - 04
2
2021 - 07 - 29
2
2021 - 07 - 12
2
2021 - 06 - 25
2
2021 - 06 - 24
4
2021 - 06 - 23
2
2021 - 06 - 22
3
2021 - 06 - 21
2
2021 - 06 - 17
2
2021 - 06 - 10
2
2021 - 06 - 09
2
2021 - 06 - 04
5
2021 - 05 - 20
3
2021 - 05 - 06
2
2021 - 04 - 15
2
2021 - 04 - 14
2
2021 - 04 - 13
3
2021 - 03 - 22
2
2021 - 03 - 19
2
2021 - 03 - 18
2
2021 - 03 - 15
2
2021 - 03 - 11
4
2021 - 03 - 09
2
2021 - 03 - 04
2
2021 - 01 - 11
2
Crawled Time
00:00
19
00:20
2
01:00
17
02:00
2
03:00
3
04:00
3
04:20
1
06:00
5
07:00
7
08:00
6
09:00
7
09:52
1
10:00
7
10:51
1
11:00
33
11:33
3
12:00
41
12:03
1
12:06
1
12:15
12
12:20
6
12:30
1
12:34
1
13:00
44
13:01
1
13:07
1
13:15
5
13:17
1
13:20
19
13:27
1
13:30
3
13:52
1
14:00
39
14:01
1
14:03
2
14:15
3
14:20
6
14:30
10
15:00
22
15:15
2
15:17
1
15:20
3
15:30
4
15:49
1
15:56
1
15:59
1
16:00
14
16:20
2
17:00
17
17:43
1
18:00
12
18:11
1
18:32
1
19:00
11
19:47
1
20:00
24
21:00
17
21:03
1
22:00
27
23:00
19
Source
galmedpharma.com
1
investor.assemblybio.com
1
ir.voyagertherapeutics.com
1
www.biospace.com
274
www.fda.gov
19
www.globenewswire.com
80
www.igmbio.com
1
www.nurixtx.com
1
www.prnewswire.com
122
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
GILD
save search
Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by C-Reactive Protein
Published:
2022-07-06
(Crawled : 13:00)
- biospace.com/
HGEN
|
$0.0361
-61.5%
120M
|
Health Technology
|
-98.01%
|
O:
0.0%
H:
27.62%
C:
14.36%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
7.65%
|
O:
0.72%
H:
0.41%
C:
0.18%
covid-19
treatment
lenzilumab
publication
BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland
Published:
2021-08-04
(Crawled : 12:00)
- biospace.com/
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-10.47%
|
O:
-1.98%
H:
0.73%
C:
-1.19%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-4.15%
|
O:
-0.49%
H:
0.72%
C:
-0.36%
BNTX
|
$86.19
-0.24%
-0.24%
580K
|
Health Technology
|
-75.46%
|
O:
2.61%
H:
20.19%
C:
14.8%
acquisition
therapy
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published:
2024-01-24
(Crawled : 17:00)
- prnewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-10.59%
|
O:
0.39%
H:
0.82%
C:
-0.74%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-13.6%
|
O:
0.22%
H:
0.43%
C:
-0.39%
SRNE
|
$0.028
-8.85%
42K
|
Health Technology
|
0.0%
|
O:
-63.33%
H:
263.64%
C:
127.27%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-15.79%
|
O:
0.1%
H:
0.43%
C:
-0.04%
AUTL
|
$4.8
-0.83%
-0.83%
1.2M
|
Health Technology
|
-11.96%
|
O:
-0.91%
H:
11.52%
C:
4.94%
drug
report
t-cell
global
therapy
market
HOOKIPA Reports Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Outlook
Published:
2021-03-18
(Crawled : 12:00)
- globenewswire.com
HOOK
|
$0.7695
0.92%
0.91%
170K
|
Health Technology
|
-93.92%
|
O:
0.08%
H:
9.84%
C:
6.32%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
3.9%
|
O:
-1.24%
H:
2.14%
C:
0.72%
financial results
results
Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma
Published:
2022-12-09
(Crawled : 14:00)
- biospace.com/
ACLX
|
$54.5
1.77%
1.74%
600K
|
|
154.7%
|
O:
20.66%
H:
9.21%
C:
7.11%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-25.19%
|
O:
-0.23%
H:
0.0%
C:
-1.45%
collaboration
HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Published:
2023-11-09
(Crawled : 12:00)
- globenewswire.com
HOOK
|
$0.7695
0.92%
0.91%
170K
|
Health Technology
|
52.09%
|
O:
-7.94%
H:
8.7%
C:
-4.37%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-14.08%
|
O:
-0.47%
H:
0.23%
C:
-3.29%
pharma
business
financial
IGM Biosciences Announces Second Quarter 2021 Financial Results and Provides Corporate Update
Published:
2021-08-09
(Crawled : 21:00)
- igmbio.com
IGMS
|
$7.4
-8.98%
-9.86%
450K
|
Health Technology
|
-89.54%
|
O:
0.51%
H:
7.28%
C:
5.3%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-2.69%
|
O:
0.0%
H:
0.71%
C:
-0.47%
financial results
results
bioscience
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published:
2022-11-10
(Crawled : 17:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
29.9%
|
O:
-0.06%
H:
0.0%
C:
0.0%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
12.29%
|
O:
6.22%
H:
3.13%
C:
-0.56%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
12.19%
|
O:
2.81%
H:
0.43%
C:
-0.2%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-16.87%
|
O:
0.18%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
22.15%
|
O:
2.59%
H:
0.72%
C:
0.63%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-39.51%
|
O:
1.22%
H:
0.01%
C:
-1.7%
IOVA
M
|
$11.72
-0.68%
-0.68%
3.6M
|
Health Technology
|
50.51%
|
O:
6.12%
H:
4.99%
C:
4.21%
INO
3 d
|
$10.22
-7.68%
-8.32%
400K
|
Health Technology
|
407.8%
|
O:
5.5%
H:
4.35%
C:
3.48%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-18.7%
|
O:
1.43%
H:
0.36%
C:
-1.08%
ATRA
|
$0.6917
-3.25%
-3.35%
830K
|
Health Technology
|
-82.43%
|
O:
2.58%
H:
23.12%
C:
20.85%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
11.82%
|
O:
7.08%
H:
0.84%
C:
-0.43%
ADAP
|
$0.8984
-8.98%
-9.86%
3.3M
|
Health Technology
|
-50.95%
|
O:
0.0%
H:
7.14%
C:
5.71%
covid-19
research
global
immunotherapy
report
impact
technology
market
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-03-25
(Crawled : 15:49)
- fda.gov
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-28.62%
|
O:
0.11%
H:
0.39%
C:
0.06%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
316.7%
|
O:
0.46%
H:
1.46%
C:
1.15%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-22.54%
|
O:
1.12%
H:
0.0%
C:
-0.33%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
59.06%
|
O:
-0.16%
H:
1.21%
C:
0.95%
SUPN
|
$28.88
-0.41%
-0.42%
350K
|
Health Technology
|
15.31%
|
O:
-0.32%
H:
5.23%
C:
4.43%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-5.03%
|
O:
0.89%
H:
0.5%
C:
0.41%
OTIC
|
$0.077
|
Health Technology
|
-97.09%
|
O:
-1.88%
H:
2.3%
C:
0.0%
OMER
|
$3.22
-3.59%
-3.73%
430K
|
Health Technology
|
-82.83%
|
O:
-1.44%
H:
3.5%
C:
2.24%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
4.01%
|
O:
0.67%
H:
0.15%
C:
-1.22%
BMRN
S
|
$90.08
-0.43%
-0.43%
940K
|
Health Technology
|
21.89%
|
O:
-0.72%
H:
1.06%
C:
0.76%
BCRX
|
$4.49
-1.97%
-2.0%
3M
|
Health Technology
|
-55.6%
|
O:
-4.08%
H:
7.03%
C:
6.04%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
8.74%
|
O:
0.64%
H:
0.2%
C:
-0.32%
Jounce Therapeutics Announces Pricing of $56.25 Million Public Offering of Common Stock
Published:
2021-03-10
(Crawled : 04:00)
- globenewswire.com
JNCE
|
$1.88
-2.59%
-1.85%
0
|
Health Technology
|
-83.85%
|
O:
-5.07%
H:
6.86%
C:
4.81%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
4.04%
|
O:
0.54%
H:
0.19%
C:
-1.19%
offering
HOOKIPA Pharma to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021
Published:
2021-11-03
(Crawled : 13:00)
- biospace.com/
HOOK
|
$0.7695
0.92%
0.91%
170K
|
Health Technology
|
-84.86%
|
O:
-0.4%
H:
6.8%
C:
6.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
1.76%
|
O:
0.27%
H:
2.44%
C:
2.21%
financial results
results
pharma
Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
Published:
2021-08-26
(Crawled : 00:00)
- globenewswire.com
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-16.46%
|
O:
0.57%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-6.3%
|
O:
-0.17%
H:
1.6%
C:
-0.04%
FBIO
|
$1.81
2.26%
2.21%
440K
|
Health Technology
|
-43.04%
|
O:
0.65%
H:
5.79%
C:
4.5%
merge
bioscience
Galapagos announces full year 2022 results and outlook for 2023
Published:
2023-02-23
(Crawled : 22:00)
- globenewswire.com
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-18.91%
|
O:
-0.33%
H:
0.04%
C:
-1.96%
GLPG
|
$28.9
-1.1%
-1.11%
140K
|
Health Technology
|
-26.29%
|
O:
-7.42%
H:
5.64%
C:
4.06%
year
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published:
2023-11-01
(Crawled : 18:00)
- prnewswire.com
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-23.18%
|
O:
-1.46%
H:
3.67%
C:
3.26%
ZYME
|
$8.68
-1.92%
-1.96%
730K
|
Health Technology
|
26.07%
|
O:
1.14%
H:
0.42%
C:
-0.7%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-3.66%
|
O:
1.03%
H:
0.73%
C:
0.58%
ADCT
|
$4.76
-4.03%
0.0%
280K
|
Health Technology
|
561.6%
|
O:
-0.16%
H:
6.42%
C:
4.49%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
15.06%
|
O:
-0.86%
H:
0.0%
C:
0.0%
STRO
M
|
$3.76
-1.05%
-1.06%
770K
|
Health Technology
|
47.29%
|
O:
0.39%
H:
3.86%
C:
3.86%
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
109.1%
|
O:
5.09%
H:
5.48%
C:
-1.27%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-16.54%
|
O:
-0.47%
H:
1.88%
C:
1.78%
EXEL
|
$22.47
-1.75%
-1.78%
2.6M
|
Health Technology
|
9.54%
|
O:
-2.62%
H:
1.17%
C:
-1.66%
drug
antibody
breast
cancer
treatment
global
market
Francesco M. Marincola Joins Kite as Worldwide Head of Cell Therapy Research
Published:
2021-01-19
(Crawled : 15:00)
- biospace.com/
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
5.68%
|
O:
2.21%
H:
5.29%
C:
3.62%
therapy
research
Global Rheumatology Therapeutics Market Research Report to 2027 - Featuring AbbVie, Amgen and Beckman Coulter Among Others
Published:
2022-04-26
(Crawled : 13:20)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-15.47%
|
O:
-1.81%
H:
0.0%
C:
0.0%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
4.62%
|
O:
3.09%
H:
0.0%
C:
-2.9%
UCBJY
|
$64.07
-4.38%
72K
|
Manufacturing
|
9.65%
|
O:
-0.33%
H:
0.0%
C:
-1.56%
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
0.83%
|
O:
-1.19%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-9.75%
|
O:
-0.48%
H:
0.0%
C:
0.0%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-46.84%
|
O:
3.08%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-20.72%
|
O:
2.0%
H:
0.0%
C:
0.0%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
163.24%
|
O:
0.34%
H:
1.41%
C:
-1.17%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-36.54%
|
O:
-0.09%
H:
1.26%
C:
-0.51%
VRTX
|
News
|
$393.51
0.1%
0.1%
950K
|
Health Technology
|
44.69%
|
O:
-0.22%
H:
0.43%
C:
-1.25%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-14.67%
|
O:
-0.11%
H:
0.0%
C:
0.0%
RIGL
|
$1.06
-4.51%
-4.72%
1.2M
|
Health Technology
|
-58.11%
|
O:
-0.38%
H:
4.92%
C:
-4.55%
REGN
|
$893.66
-0.84%
-0.84%
450K
|
Health Technology
|
30.54%
|
O:
-0.72%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
6.83%
|
O:
-0.13%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
3.49%
|
O:
-0.03%
H:
0.53%
C:
-1.33%
research
report
therapeutics
market
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-21
(Crawled : 00:00)
- fda.gov
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-34.5%
|
O:
0.18%
H:
1.54%
C:
1.39%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
243.52%
|
O:
0.25%
H:
2.13%
C:
1.63%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-27.4%
|
O:
0.21%
H:
0.83%
C:
0.33%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
44.91%
|
O:
0.5%
H:
1.37%
C:
0.91%
XERS
|
$1.77
-0.56%
-0.56%
1.1M
|
Health Technology
|
-56.69%
|
O:
0.24%
H:
0.73%
C:
-4.13%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-12.77%
|
O:
-0.32%
H:
0.17%
C:
-0.13%
OTIC
|
$0.077
|
Health Technology
|
-96.58%
|
O:
0.0%
H:
3.98%
C:
-1.33%
OMER
|
$3.22
-3.59%
-3.73%
430K
|
Health Technology
|
-77.82%
|
O:
1.39%
H:
0.79%
C:
0.33%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
0.48%
|
O:
0.57%
H:
0.86%
C:
0.54%
BCRX
|
$4.49
-1.97%
-2.0%
3M
|
Health Technology
|
-70.58%
|
O:
0.5%
H:
4.88%
C:
4.7%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
11.84%
|
O:
0.4%
H:
0.53%
C:
0.25%
Matinas BioPharma Announces Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate Oral Formulations of Gilead’s Antiviral Remdesivir Utilizing Matinas’ LNC Platform Delivery Technology
Published:
2020-12-07
(Crawled : 12:00)
- globenewswire.com
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
8.72%
|
O:
0.17%
H:
0.06%
C:
-1.35%
MTNB
|
$0.19
-1.04%
0.0%
960K
|
Health Technology
|
-82.57%
|
O:
10.09%
H:
4.17%
C:
-7.5%
biopharma
collaboration
disease
announces collaboration
liver
infectious disease
antiviral
Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors
Published:
2021-01-06
(Crawled : 17:00)
- biospace.com/
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
11.55%
|
O:
-0.5%
H:
3.98%
C:
3.77%
therapy
collaboration
cancer
blood
ford
research
solid tumors
Trodelvy® Significantly Improves Overall Survival in Pre-Treated HR+/HER2- Metastatic Breast Cancer Patients in the TROPiCS-02 Study
Published:
2022-08-15
(Crawled : 16:00)
- biospace.com/
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
6.31%
|
O:
1.41%
H:
3.83%
C:
3.7%
cs-02
trodelvy
cancer
study
her2-
her2
metastatic breast cancer
← Previous
1
2
3
4
5
6
7
8
9
…
24
25
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.